Astrazeneca Plc (AZN)

Prescription drugs are a dime a dozen these days, but AstraZeneca goes after the heavy hitters: cancer, cholesterol, asthma, and psychotic problems.

February152012
AstraZeneca PLC Presents at Leerink Swann LLC's 2012 Global Healthcare Conference, Feb-15-2012
February262012
AstraZeneca PLC Presents at 10th Annual BioPartnering North America, Feb-26-2012 09:15 AM
February292012
AstraZeneca PLC Presents at Credit Suisse Group's Fourth Healthcare One-on-One Conference, Feb-29-2012
October282012
Arcturus Ventures Inc. expected to report Fiscal Year 2012 results on October 28, 2012. This event was calculated by Capital IQ (Created on November 13, 2011).
January312013
AstraZeneca PLC expected to report Fiscal Year 2012 results on January 31, 2013. This event was calculated by Capital IQ (Created on February 3, 2012).

Free! Sign up now! or log in

Current price per share

Today's gain: $-0.26 (-0.54%)

(Not an indicator of whether the price will go up or down.)

Company Detail Astrazeneca Plc